Literature DB >> 29306483

Left Ventricular Volume-Time Relation in Patients With Heart Failure With Preserved Ejection Fraction.

Michinari Hieda1, Joshua Parker1, Tanya Rajabi1, Naoki Fujimoto1, Paul S Bhella1, Anand Prasad1, Jeffrey L Hastings1, Satyam Sarma1, Benjamin D Levine2.   

Abstract

Elevated left ventricular (LV) filling pressures are commonly reported in patients with heart failure with preserved ejection fraction (HFpEF) and are associated with impaired relaxation in diastole. Relaxation has been assessed by Doppler, but the methods for doing so are indirect and heavily influenced by loading conditions. The aim of this study is to assess LV volume-time relation in patients with HFpEF, when correcting for left atrial driving pressure and chamber size, using cardiac magnetic resonance imaging (cMRI). Cine short-axis views by cMRI (1.5T-magnet) at 26 Hz were used for measurement of LV volume. We compared the following diastolic parameters: peak filling rate/end-diastolic volume (PFR/EDV); PFR/EDV/pulmonary capillary wedge pressure (PFR/EDV/PCWP); time to PFR (TPFR); and %TPFR for cardiac cycle calculated by cMRI between patients with HFpEF (n = 10, 73 ± 7 years) and age-matched controls (n = 12, 70 ± 3 years). PCWP was significantly greater in the HFpEF group than in controls (HFpEF vs controls: 15.6 ± 5.2 vs 11.2 ± 1.3 mmHg, p = 0.0092). PFR/EDV was significantly slower in the HFpEF group than in controls (2.68 ± 0.85 vs 3.59 ± 0.87/s, p = 0.03), and was nearly 50% slower when corrected for left atrial driving pressure: PFR/EDV/PCWP (0.18 ± 0.07 vs 0.33 ± 0.10/s/mmHg, p = 0.002). In addition, TPFR (246 ± 17.2 vs 188 ± 15.7 ms, p = 0.04) and %TPFR of cardiac cycle (36.4 ± 10.4 vs 25.6 ± 5.9%, p = 0.012) were significantly longer in the HFpEF group than in controls. Patients with HFpEF have an abnormal volume-time relation, including lower PFR/EDV (PFR/EDV/PCWP) and prolonged TPFR, due to the impairment of active relaxation during early diastole.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2017        PMID: 29306483      PMCID: PMC6545885          DOI: 10.1016/j.amjcard.2017.11.033

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  5 in total

1.  Evaluation of elevated left ventricular end diastolic pressure in patients with preserved ejection fraction using cardiac magnetic resonance.

Authors:  Chengjie Gao; Yijing Tao; Jingwei Pan; Chengxing Shen; Jiayin Zhang; Zhili Xia; Qing Wan; Hao Wu; Yajie Gao; Hong Shen; Zhigang Lu; Meng Wei
Journal:  Eur Radiol       Date:  2019-01-10       Impact factor: 5.315

2.  Resting coronary velocity and myocardial performance in women with impaired coronary flow reserve: Results from the Women's Ischemia Syndrome Evaluation-Coronary Vascular Dysfunction (WISE-CVD) study.

Authors:  Nissi Suppogu; Janet Wei; Michael D Nelson; Galen Cook-Wiens; Susan Cheng; Chrisandra L Shufelt; Louise E J Thomson; Balaji Tamarappoo; Daniel S Berman; Bruce Samuels; Babak Azarbal; R David Anderson; John W Petersen; Eileen M Handberg; Carl J Pepine; C Noel Bairey Merz
Journal:  Int J Cardiol       Date:  2020-01-23       Impact factor: 4.164

3.  Left ventricular diastolic dysfunction and exercise intolerance in obese heart failure with preserved ejection fraction.

Authors:  T Jake Samuel; Dalane W Kitzman; Mark J Haykowsky; Bharathi Upadhya; Peter Brubaker; M Benjamin Nelson; W Gregory Hundley; Michael D Nelson
Journal:  Am J Physiol Heart Circ Physiol       Date:  2021-02-12       Impact factor: 4.733

Review 4.  The role of cardiac magnetic resonance imaging in the assessment of heart failure with preserved ejection fraction.

Authors:  Clement Lau; Mohamed M M Elshibly; Prathap Kanagala; Jeffrey P Khoo; Jayanth Ranjit Arnold; Sandeep Singh Hothi
Journal:  Front Cardiovasc Med       Date:  2022-07-18

5.  Left ventricular circumferential strain and coronary microvascular dysfunction: A report from the Women's Ischemia Syndrome Evaluation Coronary Vascular Dysfunction (WISE-CVD) Project.

Authors:  Balaji Tamarappoo; T Jake Samuel; Omeed Elboudwarej; Louise E J Thomson; Haider Aldiwani; Janet Wei; Puja Mehta; Susan Cheng; Behzad Sharif; Ahmed AlBadri; Eileen M Handberg; John Petersen; Carl J Pepine; Michael D Nelson; C Noel Bairey Merz
Journal:  Int J Cardiol       Date:  2020-11-14       Impact factor: 4.039

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.